All entries for: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd

March 10, 2026

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd

Orphan Drug Designation

treatment of pancreatic cancer

Disease Area: Rare Disease
February 9, 2026

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd

Orphan Drug Designation

treatment of gastric cancer, including gastroesophageal junction cancer

Disease Area: Rare Disease
Scroll to Top